1. World Health Organization. Global report on diabetes. Geneva: World Health Organization;2016.
2. Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea health statistics 2015: Korea National Health and Nutrition Examination Survey (KNHANES VI-3). Sejong: Korea Centers for Disease Control and Prevention;2016.
3. National Statistics Office. Population projections for Korea: 2015-2065. Seoul: Government of Korea;2016.
4. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011; 94:311–321. PMID:
22079683.
Article
5. Brinks R, Tamayo T, Kowall B, Rathmann W. Prevalence of type 2 diabetes in Germany in 2040: estimates from an epidemiological model. Eur J Epidemiol. 2012; 27:791–797. PMID:
22878939.
Article
6. Javanbakht M, Mashayekhi A, Baradaran HR, Haghdoost A, Afshin A. Projection of diabetes population size and associated economic burden through 2030 in Iran: evidence from micro-simulation Markov model and Bayesian meta-analysis. PLoS One. 2015; 10:e0132505. PMID:
26200913.
Article
7. Andersson T, Ahlbom A, Carlsson S. Diabetes prevalence in Sweden at present and projections for year 2050. PLoS One. 2015; 10:e0143084. PMID:
26619340.
Article
8. Sozmen K, Unal B, Capewell S, Critchley J, O'Flaherty M. Estimating diabetes prevalence in Turkey in 2025 with and without possible interventions to reduce obesity and smoking prevalence, using a modelling approach. Int J Public Health. 2015; 60(Suppl 1):S13–S21. PMID:
25471076.
Article
9. Holman N, Forouhi NG, Goyder E, Wild SH. The Association of Public Health Observatories (APHO) diabetes prevalence model: estimates of total diabetes prevalence for England, 2010-2030. Diabet Med. 2011; 28:575–582. PMID:
21480968.
Article
10. Honeycutt AA, Boyle JP, Broglio KR, Thompson TJ, Hoerger TJ, Geiss LS, Narayan KM. A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health Care Manag Sci. 2003; 6:155–164. PMID:
12943151.
11. Gregg EW, Boyle JP, Thompson TJ, Barker LE, Albright AL, Williamson DF. Modeling the impact of prevention policies on future diabetes prevalence in the United States: 2010-2030. Popul Health Metr. 2013; 11:18. PMID:
24047329.
Article
12. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010; 8:29. PMID:
20969750.
Article
13. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring). 2008; 16:2323–2330. PMID:
18719634.
Article
14. Maddams J, Utley M, Moller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer. 2012; 107:1195–1202. PMID:
22892390.
Article
15. Brookmeyer R, Abdalla N, Kawas CH, Corrada MM. Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States. Alzheimers Dement. 2018; 14:121–129. PMID:
29233480.
Article
16. Finkelstein EA, Khavjou OA, Thompson H, Trogdon JG, Pan L, Sherry B, Dietz W. Obesity and severe obesity forecasts through 2030. Am J Prev Med. 2012; 42:563–570. PMID:
22608371.
Article
17. National Statistics Office. Population projections for Korea: 2010-2060. Seoul: Government of Korea;2011.
18. Korean Diabetes Association. Diabetes fact sheet in Korea 2016. Seoul: Korean Diabetes Association;2016.
19. Koska J, Stefan N, Votruba SB, Smith SR, Krakoff J, Bunt JC. Distribution of subcutaneous fat predicts insulin action in obesity in sex-specific manner. Obesity (Silver Spring). 2008; 16:2003–2009. PMID:
18551127.
Article
20. Asia Pacific Cohort Studies Collaboration. Ni Mhurchu C, Parag V, Nakamura M, Patel A, Rodgers A, Lam TH. Body mass index and risk of diabetes mellitus in the Asia-Pacific region. Asia Pac J Clin Nutr. 2006; 15:127–133. PMID:
16672195.
21. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007; 298:2654–2664. PMID:
18073361.
22. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010; 33:414–420. PMID:
19910503.
23. Yu M, Zhang X, Lu F, Fang L. Depression and risk for diabetes: a meta-analysis. Can J Diabetes. 2015; 39:266–272. PMID:
25773933.
Article
24. Sui H, Sun N, Zhan L, Lu X, Chen T, Mao X. Association between work-related stress and risk for type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. PLoS One. 2016; 11:e0159978. PMID:
27513574.
Article
25. Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care. 2005; 28:719–725. PMID:
15735217.